Alyeska Group discloses 9.90% Suncrete (RMIX) stake via common stock and warrants

Rhea-AI Filing Summary

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report beneficial ownership of 4,698,049 shares of Suncrete, Inc. Class A common stock, representing 9.90% of the outstanding shares as of June 30, 2026. All voting and dispositive power over these shares is reported as shared, with no sole voting or dispositive power.

The position consists of 3,464,007 common shares (including 3,452,829 acquired in a private placement) and 1,234,042 shares issuable upon exercise of pre-funded warrants. Although the reporting persons hold pre-funded warrants exercisable for 2,525,094 shares, a 9.9% beneficial ownership limitation restricts additional exercises based on 47,455,043 shares outstanding. The filing notes the position is held by Alyeska Master Fund, L.P., with Alyeska Investment Group exercising voting and investment control.

Key Figures

Beneficially owned shares: 4,698,049 shares Percent of class: 9.90% Common shares held: 3,464,007 shares +5 more

8 metrics

Beneficially owned shares 4,698,049 shares Total Suncrete Class A common stock beneficially owned by reporting persons as of June 30, 2026

Percent of class 9.90% Percentage of Suncrete outstanding common stock represented by the 4,698,049 beneficially owned shares

Common shares held 3,464,007 shares Suncrete common stock held, including 3,452,829 shares acquired in a private placement

Private placement shares 3,452,829 shares Portion of common shares acquired in a private placement transaction

Exercisable warrant shares 1,234,042 shares Shares issuable upon exercise of pre-funded warrants within the 9.9% ownership cap

Total warrant capacity 2,525,094 shares Total Suncrete shares underlying pre-funded warrants held by the reporting persons

Shares outstanding baseline 47,455,043 shares Suncrete common shares outstanding per Form 10-Q dated May 15, 2026

Beneficial ownership limit 9.9% Ownership cap embedded in the pre-funded warrants restricting further exercises

Key Terms

Schedule 13G, beneficial ownership limitation, pre-funded warrants, shared voting power, +2 more

6 terms

Schedule 13G regulatory

"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial ownership limitation regulatory

"such warrants contain a beneficial ownership limitation that prohibits exercise to the extent it would cause"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

pre-funded warrants financial

"1,234,042 shares issuable upon exercise of pre-funded warrants. The Reporting Persons hold pre-funded warrants exercisable"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

shared voting power financial

"Shared Voting Power 4,698,049.00 7 | Sole Dispositive Power 0.00 8 | Shared Dispositive Power 4,698,049.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 4,698,049.00"

beneficially own financial

"As of 30 June 2026, the Reporting Persons beneficially own 4,698,049 shares of Common Stock, consisting of"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

FAQ

What percentage of Suncrete, Inc. (RMIX) does Alyeska report owning?

Alyeska and related reporting persons report beneficial ownership of 4,698,049 shares of Suncrete, Inc. Class A common stock, representing 9.90% of the outstanding shares, based on 47,455,043 shares of common stock outstanding as referenced in a May 15, 2026 Form 10-Q.

How many Suncrete (RMIX) shares does Alyeska hold through common stock vs. warrants?

The reporting persons hold 3,464,007 common shares of Suncrete, Inc., including 3,452,829 from a private placement, plus 1,234,042 shares issuable upon exercise of pre-funded warrants, for total reported beneficial ownership of 4,698,049 shares as of June 30, 2026.

What is the beneficial ownership limitation on Alyeska’s Suncrete (RMIX) pre-funded warrants?

The pre-funded warrants held by the reporting persons include a 9.9% beneficial ownership limitation, which prohibits exercise if it would cause beneficial ownership to exceed 9.9% of Suncrete’s outstanding common stock, thereby limiting the exercisable portion of the total warrant position.

How many Suncrete (RMIX) warrant shares can Alyeska currently exercise?

Although the reporting persons hold pre-funded warrants exercisable for 2,525,094 shares of Suncrete common stock, the 9.9% beneficial ownership cap allows exercise of only 1,234,042 warrant shares, after giving effect to the 3,464,007 common shares already held.

Who controls voting and investment decisions for Alyeska’s Suncrete (RMIX) position?

The Suncrete position is held by Alyeska Master Fund, L.P., with Alyeska Investment Group, L.P. exercising voting and investment control. Anand Parekh, as CEO of Alyeska Investment Group, may be deemed a beneficial owner but disclaims beneficial ownership of the shares.

What type of SEC filing did Alyeska submit for its Suncrete (RMIX) stake?

The reporting persons submitted a Schedule 13G, which reports passive beneficial ownership of Suncrete, Inc. Class A common stock. It details share counts, warrant holdings, percentage ownership, and the 9.9% beneficial ownership limitation applicable to the pre-funded warrants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:31 PM Accepted by SEC EDGAR 08/14/2026 - 04:26 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Suncrete, Inc.

(Name of Issuer)

Class A common stock, par value $0.0001 per share

(Title of Class of Securities)

86723E104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 86723E104

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,698,049.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,698,049.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,698,049.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.90 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 86723E104

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,698,049.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,698,049.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,698,049.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.90 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 86723E104

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,698,049.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,698,049.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,698,049.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.90 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Suncrete, Inc.
(b)	Address of issuer's principal executive offices: 521 E. 2nd Street, Tulsa, Oklahoma 74120
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Class A common stock, par value $0.0001 per share
(e)	CUSIP Number(s): 86723E104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,698,049
(b)	Percent of class: 9.90%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 4,698,049
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 4,698,049
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2026

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2026

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	08/14/2026

Exhibit Information

As of 30 June 2026, the Reporting Persons beneficially own 4,698,049 shares of Common Stock, consisting of (i) 3,464,007 shares of Common Stock (of which 3,452,829 were acquired in a private placement) and (ii) 1,234,042 shares issuable upon exercise of pre-funded warrants. The Reporting Persons hold pre-funded warrants exercisable for 2,525,094 shares; however, such warrants contain a beneficial ownership limitation that prohibits exercise to the extent it would cause the holder's beneficial ownership to exceed 9.9% of the outstanding Common Stock. Based on 47,455,043 shares of Common Stock outstanding (per the Form 10-Q dated 15 May 2026), the 9.9% limitation permits exercise of only 1,234,042 warrant shares after giving effect to the 3,464,007 shares otherwise held. Position held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., as investment manager, exercises voting and investment control over the shares held by Alyeska Master Fund, L.P. Anand Parekh, as Chief Executive Officer of Alyeska Investment Group, L.P., may be deemed the beneficial owner of such shares. Mr. Parekh disclaims beneficial ownership of such shares. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.